{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:44:51Z","timestamp":1792143891131,"version":"4.4.0"},"publisher-location":"New York, NY","reference-count":155,"publisher":"Springer US","isbn-type":[{"value":"9781071655863","type":"print"},{"value":"9781071655870","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5587-0_26","type":"book-chapter","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:11:37Z","timestamp":1792123897000},"page":"419-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Practical Compass to Biological Digital Resources and Omics Integration in Ewing Sarcoma"],"prefix":"10.1007","author":[{"given":"Cl\u00e9mence","family":"Henon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan B.","family":"Koster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Waterfall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G. P.","family":"Gr\u00fcnewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"26_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-022-00393-3","volume":"8","author":"F Cidre-Aranaz","year":"2022","unstructured":"Cidre-Aranaz F et al. (2022) Small round cell sarcomas. Nat Rev Dis Primer 8:1\u201322","journal-title":"Nat Rev Dis Primer"},{"key":"26_CR2","doi-asserted-by":"crossref","first-page":"eaam8419","DOI":"10.1126\/science.aam8419","volume":"361","author":"ND Anderson","year":"2018","unstructured":"Anderson ND et al. (2018) Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors. Science 361:eaam8419","journal-title":"Science"},{"key":"26_CR3","doi-asserted-by":"crossref","first-page":"e1004475","DOI":"10.1371\/journal.pgen.1004475","volume":"10","author":"AS Brohl","year":"2014","unstructured":"Brohl AS et al. (2014) The genomic landscape of the Ewing sarcoma family of tumors reveals recurrent STAG2 mutation. PLoS Genet 10:e1004475","journal-title":"PLoS Genet"},{"key":"26_CR4","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1158\/2159-8290.CD-13-1037","volume":"4","author":"BD Crompton","year":"2014","unstructured":"Crompton BD et al. (2014) The genomic landscape of pediatric Ewing sarcoma. Cancer Discov 4:1326\u20131341","journal-title":"Cancer Discov"},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-14-0622","volume":"4","author":"F Tirode","year":"2014","unstructured":"Tirode F et al. (2014) Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov 4:1342\u20131353","journal-title":"Cancer Discov"},{"key":"26_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2407-9-17","volume":"9","author":"S Savola","year":"2009","unstructured":"Savola S et al. (2009) Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors. BMC Cancer 9:17","journal-title":"BMC Cancer"},{"key":"26_CR7","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1038\/sj.onc.1210845","volume":"27","author":"BI Ferreira","year":"2008","unstructured":"Ferreira BI et al. (2008) Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing\u2019s sarcoma. Oncogene 27:2084\u20132090","journal-title":"Oncogene"},{"key":"26_CR8","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/1078-0432.CCR-24-0148","volume":"30","author":"JK Dermawan","year":"2024","unstructured":"Dermawan JK et al. (2024) Developing novel genomic risk stratification models in soft tissue and uterine leiomyosarcoma. Clin Cancer Res 30:2260\u20132271","journal-title":"Clin Cancer Res"},{"key":"26_CR9","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1038\/s41467-022-30453-x","volume":"13","author":"BA Nacev","year":"2022","unstructured":"Nacev BA et al. (2022) Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets. Nat Commun 13:3405","journal-title":"Nat Commun"},{"key":"26_CR10","doi-asserted-by":"crossref","first-page":"e0153546","DOI":"10.1371\/journal.pone.0153546","volume":"11","author":"N Zhang","year":"2016","unstructured":"Zhang N et al. (2016) Molecular heterogeneity of Ewing sarcoma as detected by ion torrent sequencing. PLoS ONE 11:e0153546","journal-title":"PLoS ONE"},{"key":"26_CR11","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1158\/1078-0432.CCR-14-2744","volume":"21","author":"K Agelopoulos","year":"2015","unstructured":"Agelopoulos K et al. (2015) Deep sequencing in conjunction with expression and functional analyses reveals activation of FGFR1 in Ewing sarcoma. Clin Cancer Res 21:4935\u20134946","journal-title":"Clin Cancer Res"},{"key":"26_CR12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/onc.2011.317","volume":"31","author":"C Mackintosh","year":"2012","unstructured":"Mackintosh C et al. (2012) 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma. Oncogene 31:1287\u20131298","journal-title":"Oncogene"},{"key":"26_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nm.4273","volume":"23","author":"NC Sheffield","year":"2017","unstructured":"Sheffield NC et al. (2017) DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma. Nat Med 23:386\u2013395","journal-title":"Nat Med"},{"key":"26_CR14","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1158\/2159-8290.CD-21-1136","volume":"12","author":"P Berlanga","year":"2022","unstructured":"Berlanga P et al. (2022) The European MAPPYACTS Trial: precision medicine program in pediatric and adolescent patients with recurrent malignancies. Cancer Discov 12:1266\u20131281","journal-title":"Cancer Discov"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cjp2.9","volume":"1","author":"SL Volchenboum","year":"2015","unstructured":"Volchenboum SL et al. (2015) Gene expression profiling of Ewing sarcoma tumors reveals the prognostic importance of tumor-stromal interactions: a report from the Children\u2019s Oncology Group. J. Pathol. Clin. Res. 1:83\u201394","journal-title":"J. Pathol. Clin. Res."},{"key":"26_CR16","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.4161\/15592294.2014.988048","volume":"9","author":"LK Svoboda","year":"2014","unstructured":"Svoboda LK et al. (2014) Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs. Epigenetics 9:1613\u20131625","journal-title":"Epigenetics"},{"key":"26_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ng.1085","volume":"44","author":"S Postel-Vinay","year":"2012","unstructured":"Postel-Vinay S et al. (2012) Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat Genet 44:323\u2013327","journal-title":"Nat Genet"},{"key":"26_CR18","first-page":"168712","volume":"2011","author":"S Savola","year":"2011","unstructured":"Savola S et al. (2011) High expression of complement component 5 (C5) at tumor site associates with superior survival in Ewing\u2019s sarcoma family of tumour patients. ISRN Oncol 2011:168712","journal-title":"ISRN Oncol"},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1200\/JCO.2008.19.2542","volume":"27","author":"K Scotlandi","year":"2009","unstructured":"Scotlandi K et al. (2009) Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome. J Clin Oncol 27:2209\u20132216","journal-title":"J Clin Oncol"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejca.2008.01.020","volume":"44","author":"K-L Schaefer","year":"2008","unstructured":"Schaefer K-L et al. (2008) Microarray analysis of Ewing\u2019s sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur J Cancer 44:699\u2013709","journal-title":"Eur J Cancer"},{"key":"26_CR21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccr.2007.02.027","volume":"11","author":"F Tirode","year":"2007","unstructured":"Tirode F et al. (2007) Mesenchymal stem cell features of Ewing tumors. Cancer Cell 11:421\u2013429","journal-title":"Cancer Cell"},{"key":"26_CR22","doi-asserted-by":"crossref","first-page":"e41770","DOI":"10.1371\/journal.pone.0041770","volume":"7","author":"L Martignetti","year":"2012","unstructured":"Martignetti L et al. (2012) Antagonism pattern detection between microRNA and target expression in Ewing\u2019s sarcoma. PLoS ONE 7:e41770","journal-title":"PLoS ONE"},{"key":"26_CR23","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1158\/1078-0432.CCR-24-2040","volume":"31","author":"A Goodspeed","year":"2025","unstructured":"Goodspeed A et al. (2025) Single-cell RNA sequencing of Ewing sarcoma tumors demonstrates transcriptional heterogeneity and clonal evolution. Clin Cancer Res 31:2010\u20132023","journal-title":"Clin Cancer Res"},{"key":"26_CR24","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1158\/2767-9764.CRC-23-0027","volume":"3","author":"LL Visser","year":"2023","unstructured":"Visser LL et al. (2023) Ewing Sarcoma single-cell transcriptome analysis reveals functionally impaired antigen-presenting cells. Cancer Res Commun 3:2158\u20132169","journal-title":"Cancer Res Commun"},{"key":"26_CR25","doi-asserted-by":"publisher","unstructured":"Hong B et al (2022) Single-cell transcriptional profiling reveals heterogeneity and developmental trajectories of Ewing sarcoma. J Cancer Res Clin Oncol https:\/\/doi.org\/10.1007\/s00432-022-04073-3","DOI":"10.1007\/s00432-022-04073-3"},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-25-0635","volume":"31","author":"C Kuo","year":"2025","unstructured":"Kuo C et al. (2025) Spatial profiling identifies tumor-associated stroma enrichment and MIF as potential immunotherapy targets in primary Ewing sarcomas. Clin Cancer Res 31:5051\u20135069","journal-title":"Clin Cancer Res"},{"key":"26_CR27","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/1078-0432.CCR-23-2187","volume":"30","author":"B Mooney","year":"2023","unstructured":"Mooney B et al. (2023) Surface and global proteome analyses identify ENPP1 and other surface proteins as actionable immunotherapeutic targets in Ewing sarcoma. Clin Cancer Res 30:1022","journal-title":"Clin Cancer Res"},{"key":"26_CR28","doi-asserted-by":"crossref","first-page":"111761","DOI":"10.1016\/j.celrep.2022.111761","volume":"41","author":"MF Orth","year":"2022","unstructured":"Orth MF et al. (2022) Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation. Cell Rep 41:111761","journal-title":"Cell Rep"},{"key":"26_CR29","unstructured":"New cell lines expanding the diversity of Ewing sarcoma models\u2014Kerkhoff (2026) Int J Cancer. Wiley Online Library. https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.70172"},{"key":"26_CR30","volume":"14","author":"OG Waltner","year":"2025","unstructured":"Waltner OG et al. (2025) Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma. eLife 14:RP109124.","journal-title":"eLife"},{"key":"26_CR31","unstructured":"dbGaP Study: National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments. https:\/\/www.ncbi.nlm.nih.gov\/projects\/gap\/cgi-bin\/study.cgi?study_id=phs000218.v19.p7"},{"key":"26_CR32","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1158\/2159-8290.CD-21-0094","volume":"11","author":"CM van Tilburg","year":"2021","unstructured":"van Tilburg CM et al. (2021) The Pediatric Precision Oncology INFORM Registry: clinical outcome and benefit for patients with very high-evidence targets. Cancer Discov 11:2764\u20132779","journal-title":"Cancer Discov"},{"key":"26_CR33","unstructured":"European Embryonal Tumour Pipeline, FP6 CORDIS | European Commission. https:\/\/cordis.europa.eu\/project\/id\/37260\/reporting"},{"key":"26_CR34","unstructured":"7th Framework Programme for Research. European Commission. https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/hu\/memo_16_146"},{"key":"26_CR35","unstructured":"ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours | ASSET | Project | Fact Sheet | FP7. CORDIS | European Commission. https:\/\/cordis.europa.eu\/project\/id\/259348."},{"key":"26_CR36","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/ijc.32651","volume":"147","author":"T de Rojas","year":"2020","unstructured":"de Rojas T et al. (2020) EORTC SPECTA-AYA: a unique molecular profiling platform for adolescents and young adults with cancer in Europe. Int J Cancer 147:1180\u20131184","journal-title":"Int J Cancer"},{"key":"26_CR37","unstructured":"individualizedPaediatricCure: cloud-based virtual-patient models for precision paediatric oncology | iPC | Project | Results | H2020. CORDIS | European Commission. https:\/\/cordis.europa.eu\/project\/id\/826121\/results"},{"key":"26_CR38","doi-asserted-by":"crossref","first-page":"100212","DOI":"10.1016\/j.ejcped.2024.100212","volume":"5","author":"G Vassal","year":"2025","unstructured":"Vassal G (2025) UNCAN.eu, the European platform to understand cancer, and childhood cancers. EJC Paediatr Oncol 5:100212","journal-title":"EJC Paediatr Oncol"},{"key":"26_CR39","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1158\/1078-0432.CCR-17-0381","volume":"23","author":"AC Harttrampf","year":"2017","unstructured":"Harttrampf AC et al. (2017) Molecular screening for cancer treatment optimization (MOSCATO-01) in pediatric patients: a single-institutional prospective molecular stratification trial. Clin Cancer Res 23:6101\u20136112","journal-title":"Clin Cancer Res"},{"key":"26_CR40","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1200\/JCO-25-00157","volume":"43","author":"R Gillani","year":"2025","unstructured":"Gillani R et al. (2025) Molecular characterization informs prognosis in patients with localized Ewing sarcoma: a report from the Children\u2019s Oncology Group. J Clin Oncol 43:3750\u20133759","journal-title":"J Clin Oncol"},{"key":"26_CR41","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(22)01790-1","volume":"400","author":"B Brennan","year":"2022","unstructured":"Brennan B et al. (2022) Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial. The Lancet 400:1513\u20131521","journal-title":"The Lancet"},{"key":"26_CR42","doi-asserted-by":"crossref","first-page":"105008","DOI":"10.1016\/j.yexmp.2025.105008","volume":"144","author":"J D\u00edaz-Mart\u00edn","year":"2025","unstructured":"D\u00edaz-Mart\u00edn J et al. (2025) Prospective evaluation of copy number alterations validates chromosome 1q gain as an independent marker of poor prognosis in localized Ewing sarcoma. Exp Mol Pathol 144:105008","journal-title":"Exp Mol Pathol"},{"key":"26_CR43","doi-asserted-by":"publisher","first-page":"160018","DOI":"10.1038\/sdata.2016.18","volume":"3","author":"MD Wilkinson","year":"2016","unstructured":"Wilkinson MD et al. (2016) The FAIR Guiding Principles for scientific data management and stewardship. Sci Data 3:160018","journal-title":"Sci Data"},{"key":"26_CR44","doi-asserted-by":"crossref","first-page":"100029","DOI":"10.1016\/j.xgen.2021.100029","volume":"1","author":"HL Rehm","year":"2021","unstructured":"Rehm HL et al. (2021) GA4GH: international policies and standards for data sharing across genomic research and healthcare. Cell Genomics 1:100029","journal-title":"Cell Genomics"},{"key":"26_CR45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/359162a0","volume":"359","author":"O Delattre","year":"1992","unstructured":"Delattre O et al. (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162\u2013165","journal-title":"Nature"},{"key":"26_CR46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/gcc.23128","volume":"62","author":"J Wang","year":"2023","unstructured":"Wang J et al. (2023) A cloud-based resource for genome coordinate-based exploration and large-scale analysis of chromosome aberrations and gene fusions in cancer. Genes Chromosomes Cancer 62:441\u2013448","journal-title":"Genes Chromosomes Cancer"},{"key":"26_CR47","doi-asserted-by":"crossref","first-page":"D817","DOI":"10.1093\/nar\/gkz1018","volume":"48","author":"YE Jang","year":"2020","unstructured":"Jang YE et al. (2020) ChimerDB 4.0: an updated and expanded database of fusion genes. Nucleic Acids Res 48:D817\u2013D824","journal-title":"Nucleic Acids Res"},{"key":"26_CR48","doi-asserted-by":"crossref","first-page":"e0196588","DOI":"10.1371\/journal.pone.0196588","volume":"13","author":"P Panigrahi","year":"2018","unstructured":"Panigrahi P, Jere A, Anamika K (2018) FusionHub: a unified web platform for annotation and visualization of gene fusion events in human cancer. PloS ONE 13:e0196588","journal-title":"PloS ONE"},{"key":"26_CR49","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkx1018","volume":"46","author":"X Hu","year":"2018","unstructured":"Hu X et al. (2018) TumorFusions: an integrative resource for cancer-associated transcript fusions. Nucleic Acids Res 46:D1144\u2013D1149","journal-title":"Nucleic Acids Res"},{"key":"26_CR50","doi-asserted-by":"crossref","first-page":"D994","DOI":"10.1093\/nar\/gky1067","volume":"47","author":"P Kim","year":"2019","unstructured":"Kim P, Zhou X (2019) FusionGDB: fusion gene annotation DataBase. Nucleic Acids Res 47:D994\u2013D1004","journal-title":"Nucleic Acids Res"},{"key":"26_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13000-015-0310-4","volume":"10","author":"Y Wang","year":"2015","unstructured":"Wang Y, Wu N, Liu J, Wu Z, Dong D (2015) FusionCancer: a database of cancer fusion genes derived from RNA-seq data. Diagn Pathol 10:131","journal-title":"Diagn Pathol"},{"key":"26_CR52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/gm129","volume":"2","author":"H Kovar","year":"2010","unstructured":"Kovar H (2010) Downstream EWS\/FLI1\u2014upstream Ewing\u2019s sarcoma. Genome Med 2:8","journal-title":"Genome Med"},{"key":"26_CR53","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1101\/gad.1899710","volume":"24","author":"N Riggi","year":"2010","unstructured":"Riggi N et al. (2010) EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev 24:916\u2013932","journal-title":"Genes Dev"},{"key":"26_CR54","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ccr.2006.04.004","volume":"9","author":"R Smith","year":"2006","unstructured":"Smith R et al. (2006) Expression profiling of EWS\/FLI identifies NKX2.2 as a critical target gene in Ewing\u2019s sarcoma. Cancer Cell 9:405\u2013416","journal-title":"Cancer Cell"},{"key":"26_CR55","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/ng.3921","volume":"49","author":"V Boeva","year":"2017","unstructured":"Boeva V et al. (2017) Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. Nat Genet 49:1408\u20131413","journal-title":"Nat Genet"},{"key":"26_CR56","doi-asserted-by":"publisher","unstructured":"Federico A et al (2026) The ITCC-P4 PDX platform of pediatric cancers for preclinical testing. https:\/\/doi.org\/10.64898\/2026.02.04.703023","DOI":"10.64898\/2026.02.04.703023"},{"key":"26_CR57","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1158\/1538-7445.AM2025-3820","volume":"85","author":"Z Perova","year":"2025","unstructured":"Perova Z et al. (2025) Abstract 3820: CancerModels.Org: a comprehensive resource for advancing precision medicine in cancer research. Cancer Res 85:3820","journal-title":"Cancer Res"},{"key":"26_CR58","doi-asserted-by":"crossref","first-page":"D1073","DOI":"10.1093\/nar\/gky984","volume":"47","author":"N Conte","year":"2019","unstructured":"Conte N et al. (2019) PDX Finder: a portal for patient-derived tumor xenograft model discovery. Nucleic Acids Res 47:D1073\u2013D1079","journal-title":"Nucleic Acids Res"},{"key":"26_CR59","doi-asserted-by":"publisher","first-page":"7689","DOI":"10.1038\/s41467-025-62673-2","volume":"16","author":"FCAS Ringnalda","year":"2025","unstructured":"Ringnalda FCAS et al. (2025) Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition. Nat Commun 16:7689","journal-title":"Nat Commun"},{"key":"26_CR60","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak A et al. (2017) Defining a cancer dependency map. Cell 170:564\u2013576.e16","journal-title":"Cell"},{"key":"26_CR61","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG et al. (2019) COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res 47:D941\u2013D947","journal-title":"Nucleic Acids Res"},{"key":"26_CR62","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS et al. (2013) Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499:214\u2013218","journal-title":"Nature"},{"key":"26_CR63","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1002\/j.1460-2075.1993.tb06137.x","volume":"12","author":"J Zucman","year":"1993","unstructured":"Zucman J et al. (1993) Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 12:4481\u20134487","journal-title":"EMBO J"},{"key":"26_CR64","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/ng0294-146","volume":"6","author":"PHB Sorensen","year":"1994","unstructured":"Sorensen PHB et al. (1994) A second Ewing\u2019s sarcoma translocation, t(21;22), fuses the EWS gene to another ETS\u2013family transcription factor, ERG. Nat Genet 6:146\u2013151","journal-title":"Nat Genet"},{"key":"26_CR65","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/sj.onc.1200933","volume":"14","author":"M Peter","year":"1997","unstructured":"Peter M et al. (1997) A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14:1159\u20131164","journal-title":"Oncogene"},{"key":"26_CR66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2353\/jmoldx.2007.070009","volume":"9","author":"TL Ng","year":"2007","unstructured":"Ng TL et al. (2007) Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J Mol Diagn 9:459\u2013463","journal-title":"J Mol Diagn"},{"key":"26_CR67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jjco\/hyaf174","volume":"56","author":"S Kamio","year":"2026","unstructured":"Kamio S et al. (2026) Analysis of comprehensive genomic profiling test for Ewing sarcoma in pediatric patients and adults using the nationwide clinical and genomic database in Japan. Jpn J Clin Oncol 56:33\u201339","journal-title":"Jpn J Clin Oncol"},{"key":"26_CR68","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ccell.2021.04.001","volume":"39","author":"D Surdez","year":"2021","unstructured":"Surdez D et al. (2021) STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma. Cancer Cell 39:810\u2013826. e9","journal-title":"Cancer Cell"},{"key":"26_CR69","first-page":"241","volume":"25","author":"P Jagodzi\u0144ska-Mucha","year":"2021","unstructured":"Jagodzi\u0144ska-Mucha P et al. (2021) Mutational landscape of primary and recurrent Ewing sarcoma. Contemp Oncol 25:241\u2013248","journal-title":"Contemp Oncol"},{"key":"26_CR70","doi-asserted-by":"crossref","unstructured":"Adane B et al (2021) STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma. Cancer Cell 39:827\u2013844.e10","DOI":"10.1016\/j.ccell.2021.05.007"},{"key":"26_CR71","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41416-021-01438-2","volume":"125","author":"DL Casey","year":"2021","unstructured":"Casey DL et al. (2021) TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma. Br J Cancer 125:576\u2013581","journal-title":"Br J Cancer"},{"key":"26_CR72","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1200\/JCO.2005.02.081","volume":"23","author":"H-Y Huang","year":"2005","unstructured":"Huang H-Y et al. (2005) Ewing sarcomas with p53 mutation or p16\/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol 23:548\u2013558","journal-title":"J Clin Oncol"},{"key":"26_CR73","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/1878-0261.70008","volume":"19","author":"A Paragji","year":"2025","unstructured":"Paragji A et al. (2025) Revisiting CDKN2A dysregulation in Ewing sarcoma. Mol Oncol 19:994\u20131001","journal-title":"Mol Oncol"},{"key":"26_CR74","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1038\/s41467-018-05537-2","volume":"9","author":"MJ Machiela","year":"2018","unstructured":"Machiela MJ et al. (2018) Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility. Nat Commun 9:3184","journal-title":"Nat Commun"},{"key":"26_CR75","doi-asserted-by":"publisher","unstructured":"Hubbard AK et al (2026) Genome-wide association study meta-analysis identifies susceptibility loci informing Ewing sarcoma etiology and potential mechanisms of risk. https:\/\/doi.org\/10.64898\/2026.02.06.26345779","DOI":"10.64898\/2026.02.06.26345779"},{"key":"26_CR76","doi-asserted-by":"publisher","unstructured":"Andrew S et al (2017) Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma Genetics in Medicine 19(8):955\u2013958 https:\/\/doi.org\/10.1038\/gim.2016.206","DOI":"10.1038\/gim.2016.206"},{"issue":"6","key":"26_CR77","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.ajhg.2022.04.007","volume":"109","author":"R Gillani","year":"2022","unstructured":"Riaz et al (2022) Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes. Am J Hum Genet 109(6):1026\u20131037 https:\/\/doi.org\/10.1016\/j.ajhg.2022.04.007","journal-title":"Am J Hum Genet"},{"key":"26_CR78","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/ng.3363","volume":"47","author":"TGP Gr\u00fcnewald","year":"2015","unstructured":"Gr\u00fcnewald TGP et al. (2015) Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite. Nat Genet 47:1073\u20131078","journal-title":"Nat Genet"},{"key":"26_CR79","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.1038\/s41467-019-12071-2","volume":"10","author":"J Musa","year":"2019","unstructured":"Musa J et al. (2019) Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes. Nat Commun 10:4128","journal-title":"Nat Commun"},{"key":"26_CR80","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4161\/cc.7.2.5229","volume":"7","author":"JD Hancock","year":"2008","unstructured":"Hancock JD, Lessnick SL (2008) A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature. Cell Cycle 7:250\u2013256","journal-title":"Cell Cycle"},{"key":"26_CR81","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.celrep.2015.01.042","volume":"10","author":"EM Tomazou","year":"2015","unstructured":"Tomazou EM et al. (2015) Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1. Cell Rep 10:1082\u20131095","journal-title":"Cell Rep"},{"key":"26_CR82","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0801073105","volume":"105","author":"K Gangwal","year":"2008","unstructured":"Gangwal K et al. (2008) Microsatellites as EWS\/FLI response elements in Ewing\u2019s sarcoma. Proc Natl Acad Sci USA 105:10149\u201310154","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR83","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1073\/pnas.1701872114","volume":"114","author":"KM Johnson","year":"2017","unstructured":"Johnson KM et al. (2017) Role for the EWS domain of EWS\/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth. Proc Natl Acad Sci USA 114:9870\u20139875","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR84","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/cancers12040948","volume":"12","author":"HE Miller","year":"2020","unstructured":"Miller HE et al. (2020) Reconstruction of Ewing sarcoma developmental context from mass-scale transcriptomics reveals characteristics of EWSR1-FLI1 permissibility. Cancers 12:948","journal-title":"Cancers"},{"key":"26_CR85","doi-asserted-by":"crossref","unstructured":"Vasileva E et al (2025) Origin of Ewing sarcoma by embryonic reprogramming of neural crest to mesoderm. Cell Rep 44","DOI":"10.1016\/j.celrep.2025.116376"},{"key":"26_CR86","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.3390\/cancers13153736","volume":"13","author":"Y Chen","year":"2021","unstructured":"Chen Y et al. (2021) Identification of an RNA-binding-protein-based prognostic model for Ewing sarcoma. Cancers 13:3736","journal-title":"Cancers"},{"key":"26_CR87","volume":"13","author":"R Jiang","year":"2022","unstructured":"Jiang R et al. (2022) A novel defined hypoxia-related gene signature for prognostic prediction of patients with Ewing sarcoma. Front Genet 13, 908113.","journal-title":"Front Genet"},{"key":"26_CR88","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/cas.15688","volume":"114","author":"Z Zhang","year":"2023","unstructured":"Zhang Z et al. (2023) Characterization of myeloid signature genes for predicting prognosis and immune landscape in Ewing sarcoma. Cancer Sci 114:1240\u20131255","journal-title":"Cancer Sci"},{"key":"26_CR89","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1038\/onc.2010.581","volume":"30","author":"J Ban","year":"2011","unstructured":"Ban J et al. (2011) Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing\u2019s sarcoma. Oncogene 30:2173\u20132180","journal-title":"Oncogene"},{"key":"26_CR90","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccr.2012.04.023","volume":"21","author":"C De Vito","year":"2012","unstructured":"De Vito C et al. (2012) A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma. Cancer Cell 21:807\u2013821","journal-title":"Cancer Cell"},{"key":"26_CR91","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/path.3007","volume":"226","author":"F Nakatani","year":"2012","unstructured":"Nakatani F et al. (2012) miR-34a predicts survival of Ewing\u2019s sarcoma patients and directly influences cell chemo-sensitivity and malignancy. J Pathol 226:796\u2013805","journal-title":"J Pathol"},{"key":"26_CR92","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3892\/ijo.2016.3379","volume":"48","author":"M Kawano","year":"2016","unstructured":"Kawano M, Tanaka K, Itonaga I, Iwasaki T, Tsumura H (2016) MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing\u2019s sarcoma cells. Int J Oncol 48:1531\u20131540","journal-title":"Int J Oncol"},{"key":"26_CR93","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3892\/ijo.2017.4155","volume":"51","author":"M Kawano","year":"2017","unstructured":"Kawano M, Tanaka K, Itonaga I, Iwasaki T, Tsumura H (2017) MicroRNA-20b promotes cell proliferation via targeting of TGF-\u03b2 receptor II and upregulates MYC expression in Ewing\u2019s sarcoma cells. Int J Oncol 51:1842\u20131850","journal-title":"Int J Oncol"},{"key":"26_CR94","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12935-018-0536-9","volume":"18","author":"M Kawano","year":"2018","unstructured":"Kawano M, Tanaka K, Itonaga I, Iwasaki T, Tsumura H (2018) MicroRNA-181c prevents apoptosis by targeting of FAS receptor in Ewing\u2019s sarcoma cells. Cancer Cell Int 18:37","journal-title":"Cancer Cell Int"},{"key":"26_CR95","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/ijms17050656","volume":"17","author":"A Parafioriti","year":"2016","unstructured":"Parafioriti A et al. (2016) Ewing\u2019s sarcoma: an analysis of mirna expression profiles and target genes in paraffin-embedded primary tumor tissue. Int J Mol Sci 17:656","journal-title":"Int J Mol Sci"},{"key":"26_CR96","doi-asserted-by":"crossref","first-page":"e93067","DOI":"10.1371\/journal.pone.0093067","volume":"9","author":"B Karnuth","year":"2014","unstructured":"Karnuth B et al. (2014) Differentially expressed miRNAs in Ewing sarcoma compared to mesenchymal stem cells: low miR-31 expression with effects on proliferation and invasion. PLoS ONE 9:e93067","journal-title":"PLoS ONE"},{"key":"26_CR97","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3390\/cancers14071762","volume":"14","author":"A De Feo","year":"2022","unstructured":"De Feo A et al. (2022) miR-214-3p is commonly downregulated by EWS-FLI1 and by CD99 and its restoration limits Ewing sarcoma aggressiveness. Cancers 14:1762","journal-title":"Cancers"},{"key":"26_CR98","doi-asserted-by":"crossref","first-page":"B021","DOI":"10.1158\/1557-3265.SARCOMAS22-B021","volume":"28","author":"MC Briones Martin del Campo","year":"2022","unstructured":"Briones Martin del Campo MC et al. (2022) Abstract B021: long non-coding RNAs that are required for robust cell growth in Ewing Sarcoma. Clin Cancer Res 28:B021","journal-title":"Clin Cancer Res"},{"key":"26_CR99","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1172\/JCI72124","volume":"124","author":"M Marques Howarth","year":"2014","unstructured":"Marques Howarth M et al. (2014) Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. J Clin Invest 124:5275\u20135290","journal-title":"J Clin Invest"},{"key":"26_CR100","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4149\/neo_2021_201110N1198","volume":"68","author":"H Li","year":"2021","unstructured":"Li H et al. (2021) LncRNA TUG1 promotes Ewing\u2019s sarcoma cell proliferation, migration, and invasion via the miR-199a-3p-MSI2 signaling pathway. Neoplasma 68:590\u2013601","journal-title":"Neoplasma"},{"key":"26_CR101","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.canlet.2019.10.026","volume":"469","author":"N Mercatelli","year":"2020","unstructured":"Mercatelli N, Fortini D, Palombo R, Paronetto MP (2020) Small molecule inhibition of Ewing sarcoma cell growth via targeting the long non coding RNA HULC. Cancer Lett 469:111\u2013123","journal-title":"Cancer Lett"},{"key":"26_CR102","doi-asserted-by":"crossref","first-page":"e11599","DOI":"10.7717\/peerj.11599","volume":"9","author":"Z Chen","year":"2021","unstructured":"Chen Z et al. (2021) A seven-lncRNA signature for predicting Ewing\u2019s sarcoma. PeerJ 9:e11599","journal-title":"PeerJ"},{"key":"26_CR103","volume":"9","author":"E Ren","year":"2021","unstructured":"Ren E et al. (2021) An immune-related long non-coding RNA signature to predict the prognosis of Ewing\u2019s sarcoma based on a machine learning iterative lasso regression. Front Cell Dev Biol 9, 651593.","journal-title":"Front Cell Dev Biol"},{"key":"26_CR104","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/j.molcel.2022.04.019","volume":"82","author":"J Vibert","year":"2022","unstructured":"Vibert J et al. (2022) Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions. Mol Cell 82:2458\u20132471.e9","journal-title":"Mol Cell"},{"key":"26_CR105","doi-asserted-by":"crossref","first-page":"zcab052","DOI":"10.1093\/narcan\/zcab052","volume":"4","author":"GT Graham","year":"2022","unstructured":"Graham GT et al. (2022) Comprehensive profiling of mRNA splicing indicates that GC content signals altered cassette exon inclusion in Ewing sarcoma. NAR Cancer 4:zcab052","journal-title":"NAR Cancer"},{"key":"26_CR106","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/cancers15020382","volume":"15","author":"L Yu","year":"2023","unstructured":"Yu L, Davis IJ, Liu P (2023) Regulation of EWSR1-FLI1 function by post-transcriptional and post-translational modifications. Cancers 15:382","journal-title":"Cancers"},{"key":"26_CR107","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3892\/ijmm.2022.5094","volume":"49","author":"E Korsching","year":"2022","unstructured":"Korsching E, Matschke J, Hotfilder M (2022) Splice variants denote differences between a cancer stem cell side population of EWSR1-ERG-based Ewing sarcoma cells, its main population and EWSR1-FLI-based cells. Int J Mol Med 49:39","journal-title":"Int J Mol Med"},{"key":"26_CR108","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1038\/s41467-025-61725-x","volume":"16","author":"B Galvan","year":"2025","unstructured":"Galvan B et al. (2025) Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma. Nat Commun 16:6537","journal-title":"Nat Commun"},{"key":"26_CR109","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/biomedicines10061325","volume":"10","author":"M Li","year":"2022","unstructured":"Li M, Chen C-W (2022) Epigenetic and transcriptional signaling in Ewing sarcoma-disease etiology and therapeutic opportunities. Biomedicines 10:1325","journal-title":"Biomedicines"},{"key":"26_CR110","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ccell.2014.10.004","volume":"26","author":"N Riggi","year":"2014","unstructured":"Riggi N et al. (2014) EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. Cancer Cell 26:668\u2013681","journal-title":"Cancer Cell"},{"key":"26_CR111","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1093\/nar\/gkac747","volume":"50","author":"IA Showpnil","year":"2022","unstructured":"Showpnil IA et al. (2022) EWS\/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma. Nucleic Acids Res 50:9814\u20139837","journal-title":"Nucleic Acids Res"},{"key":"26_CR112","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2017.07.036","volume":"171","author":"G Boulay","year":"2017","unstructured":"Boulay G et al. (2017) Cancer-specific retargeting of BAF complexes by a prion-like domain. Cell 171:163\u2013178.e19","journal-title":"Cell"},{"key":"26_CR113","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.1038\/s41467-024-51050-0","volume":"15","author":"YR Kim","year":"2024","unstructured":"Kim YR et al. (2024) Prion-like domain mediated phase separation of ARID1A promotes oncogenic potential of Ewing\u2019s sarcoma. Nat Commun 15:6569","journal-title":"Nat Commun"},{"key":"26_CR114","doi-asserted-by":"crossref","first-page":"eaba3058","DOI":"10.1126\/sciadv.aba3058","volume":"6","author":"S S\u00e1nchez-Molina","year":"2020","unstructured":"S\u00e1nchez-Molina S et al. (2020) RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis. Sci Adv 6:eaba3058","journal-title":"Sci Adv"},{"key":"26_CR115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1158\/0008-5472.CAN-22-3950","volume":"84","author":"J Graca Marques","year":"2024","unstructured":"Graca Marques J et al. (2024) The chromatin remodeler CHD4 sustains Ewing sarcoma cell survival by controlling global chromatin architecture. Cancer Res 84:241\u2013257","journal-title":"Cancer Res"},{"key":"26_CR116","doi-asserted-by":"crossref","first-page":"498472","DOI":"10.1155\/2012\/498472","volume":"2012","author":"N Patel","year":"2012","unstructured":"Patel N et al. (2012) DNA methylation and gene expression profiling of Ewing sarcoma primary tumors reveal genes that are potential targets of epigenetic inactivation. Sarcoma 2012:498472","journal-title":"Sarcoma"},{"key":"26_CR117","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3892\/ol.2014.2322","volume":"8","author":"H-R Park","year":"2014","unstructured":"Park H-R, Jung W-W, Kim H-S, Park Y-K (2014) Microarray-based DNA methylation study of Ewing\u2019s sarcoma of the bone. Oncol Lett 8:1613\u20131617","journal-title":"Oncol Lett"},{"key":"26_CR118","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canlet.2016.11.020","volume":"386","author":"J Huertas-Mart\u00ednez","year":"2017","unstructured":"Huertas-Mart\u00ednez J et al. (2017) DNA methylation profiling identifies PTRF\/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1. Cancer Lett 386:196\u2013207","journal-title":"Cancer Lett"},{"key":"26_CR119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004932","volume":"4","author":"N Guillon","year":"2009","unstructured":"Guillon N et al. (2009) The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function. PLoS ONE 4, e4932.","journal-title":"PLoS ONE"},{"key":"26_CR120","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1101\/gr.151340.112","volume":"23","author":"S Bilke","year":"2013","unstructured":"Bilke S et al. (2013) Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer. Genome Res 23:1797\u20131809","journal-title":"Genome Res"},{"key":"26_CR121","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/15592294.2020.1805678","volume":"16","author":"ER Theisen","year":"2021","unstructured":"Theisen ER et al. (2021) Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein. Epigenetics 16:405\u2013424","journal-title":"Epigenetics"},{"key":"26_CR122","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1158\/0008-5472.CAN-24-3452","volume":"85","author":"E Figuerola-Bou","year":"2025","unstructured":"Figuerola-Bou E et al. (2025) KDM6 demethylases contribute to EWSR1::FLI1-driven oncogenic reprogramming in Ewing sarcoma. Cancer Res 85:4485\u20134503","journal-title":"Cancer Res"},{"key":"26_CR123","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature25748","volume":"555","author":"A Gorthi","year":"2018","unstructured":"Gorthi A et al. (2018) EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma. Nature 555:387\u2013391","journal-title":"Nature"},{"key":"26_CR124","doi-asserted-by":"crossref","first-page":"31397","DOI":"10.18632\/oncotarget.25829","volume":"9","author":"DJ Garc\u00eda-Dom\u00ednguez","year":"2018","unstructured":"Garc\u00eda-Dom\u00ednguez DJ et al. (2018) The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma. Oncotarget 9:31397\u201331410","journal-title":"Oncotarget"},{"key":"26_CR125","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/cancers12020304","volume":"12","author":"GHS Richter","year":"2020","unstructured":"Richter GHS et al. (2020) Combined inhibition of epigenetic readers and transcription initiation targets the EWS-ETS transcriptional program in Ewing sarcoma. Cancers 12:304","journal-title":"Cancers"},{"key":"26_CR126","doi-asserted-by":"publisher","unstructured":"Ganapathi SS et al (2025) Transcriptional rewiring of BET inhibitor treated Ewing sarcoma cells augments their dependency on focal adhesion kinase. BioRxiv https:\/\/doi.org\/10.1101\/2025.09.02.673849","DOI":"10.1101\/2025.09.02.673849"},{"key":"26_CR127","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1021\/pr500387m","volume":"13","author":"DJ Elzi","year":"2014","unstructured":"Elzi DJ, Song M, Hakala K, Weintraub ST, Shiio Y (2014) Proteomic analysis of the EWS-Fli-1 interactome reveals the role of the lysosome in EWS-Fli-1 turnover. J Proteome Res 13:3783\u20133791","journal-title":"J Proteome Res"},{"key":"26_CR128","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1038\/onc.2016.498","volume":"36","author":"G-A Franzetti","year":"2017","unstructured":"Franzetti G-A et al. (2017) Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation\/migration choices in Ewing sarcoma cells. Oncogene 36:3505\u20133514","journal-title":"Oncogene"},{"key":"26_CR129","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1158\/1078-0432.CCR-08-1913","volume":"15","author":"K Kikuta","year":"2009","unstructured":"Kikuta K et al. (2009) Nucleophosmin as a candidate prognostic biomarker of Ewing\u2019s sarcoma revealed by proteomics. Clin. Cancer Res 15:2885\u20132894","journal-title":"Clin. Cancer Res"},{"key":"26_CR130","doi-asserted-by":"crossref","first-page":"djw182","DOI":"10.1093\/jnci\/djw182","volume":"108","author":"S-E Lamhamedi-Cherradi","year":"2016","unstructured":"Lamhamedi-Cherradi S-E et al. (2016) IGF-1R and mTOR blockade: novel resistance mechanisms and synergistic drug combinations for Ewing sarcoma. J Natl Cancer Inst 108:djw182","journal-title":"J Natl Cancer Inst"},{"key":"26_CR131","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1158\/1078-0432.CCR-18-0936","volume":"25","author":"P Puerto-Camacho","year":"2019","unstructured":"Puerto-Camacho P et al. (2019) Preclinical efficacy of endoglin-targeting antibody\u2013drug conjugates for the treatment of Ewing sarcoma. Clin Cancer Res 25:2228\u20132240","journal-title":"Clin Cancer Res"},{"key":"26_CR132","doi-asserted-by":"crossref","first-page":"IA011","DOI":"10.1158\/1557-3265.SARCOMAS22-IA011","volume":"28","author":"S Heitzeneder","year":"2022","unstructured":"Heitzeneder S (2022) Abstract IA011: identifying tumor-restricted target antigens for adoptive cellular immunotherapy to treat Ewing sarcoma using multi-omic discovery platforms. Clin Cancer Res 28:IA011","journal-title":"Clin Cancer Res"},{"key":"26_CR133","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/1541-7786.MCR-17-0182","volume":"15","author":"JM Tanner","year":"2017","unstructured":"Tanner JM et al. (2017) EWS\/FLI is a master regulator of metabolic reprogramming in Ewing sarcoma. Mol Cancer Res 15:1517\u20131530","journal-title":"Mol Cancer Res"},{"key":"26_CR134","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molcel.2019.05.003","volume":"75","author":"ML Suv\u00e0","year":"2019","unstructured":"Suv\u00e0 ML, Tirosh I (2019) Single-cell RNA sequencing in cancer: lessons learned and emerging challenges. Mol Cell 75:7\u201312","journal-title":"Mol Cell"},{"key":"26_CR135","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12943-024-02040-9","volume":"23","author":"Y Jin","year":"2024","unstructured":"Jin Y et al. (2024) Advances in spatial transcriptomics and its applications in cancer research. Mol Cancer 23:129","journal-title":"Mol Cancer"},{"key":"26_CR136","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.celrep.2020.01.049","volume":"30","author":"M-M Aynaud","year":"2020","unstructured":"Aynaud M-M et al. (2020) Transcriptional programs define intratumoral heterogeneity of Ewing sarcoma at single-cell resolution. Cell Rep 30:1767\u20131779.e6","journal-title":"Cell Rep"},{"key":"26_CR137","volume":"27","author":"W Mao","year":"2024","unstructured":"Mao W et al. (2024) Single-cell RNA sequencing and spatial transcriptomics of bladder Ewing sarcoma. iScience 27, 110921.","journal-title":"iScience"},{"key":"26_CR138","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12:31\u201346","journal-title":"Cancer Discov"},{"key":"26_CR139","doi-asserted-by":"crossref","first-page":"e5415","DOI":"10.1371\/journal.pone.0005415","volume":"4","author":"M Kauer","year":"2009","unstructured":"Kauer M et al. (2009) A molecular function map of Ewing\u2019s sarcoma. PLoS ONE 4:e5415","journal-title":"PLoS ONE"},{"key":"26_CR140","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1093\/nar\/gkt678","volume":"41","author":"G Stoll","year":"2013","unstructured":"Stoll G et al. (2013) Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis. Nucleic Acids Res 41:8853\u20138871","journal-title":"Nucleic Acids Res"},{"key":"26_CR141","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/nar\/gkv123","volume":"43","author":"R Schwentner","year":"2015","unstructured":"Schwentner R et al. (2015) EWS-FLI1 employs an E2F switch to drive target gene expression. Nucleic Acids Res 43:2780\u20132789","journal-title":"Nucleic Acids Res"},{"key":"26_CR142","doi-asserted-by":"crossref","first-page":"E1307","DOI":"10.1073\/pnas.1500536112","volume":"112","author":"SP Selvanathan","year":"2015","unstructured":"Selvanathan SP et al. (2015) Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. Proc Natl Acad Sci USA 112:E1307\u20131316","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR143","doi-asserted-by":"crossref","first-page":"11434","DOI":"10.1093\/nar\/gkaa901","volume":"48","author":"X Shi","year":"2020","unstructured":"Shi X et al. (2020) EWS-FLI1 regulates and cooperates with core regulatory circuitry in Ewing sarcoma. Nucleic Acids Res 48:11434\u201311451","journal-title":"Nucleic Acids Res"},{"key":"26_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-021-01470-z","volume":"21","author":"F Cidre-Aranaz","year":"2022","unstructured":"Cidre-Aranaz F et al. (2022) Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma. Mol Cancer 21:1","journal-title":"Mol Cancer"},{"key":"26_CR145","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41598-023-49930-4","volume":"14","author":"R Elkin","year":"2024","unstructured":"Elkin R et al. (2024) Dynamic network curvature analysis of gene expression reveals novel potential therapeutic targets in sarcoma. Sci Rep 14:488","journal-title":"Sci Rep"},{"key":"26_CR146","doi-asserted-by":"publisher","unstructured":"Suresh V et al (2026) Modelling EWS::FLI1 protein fluctuations reveal determinants of tumor plasticity in Ewing sarcoma. EMBO Mol Med https:\/\/doi.org\/10.1038\/s44321-025-00364-7","DOI":"10.1038\/s44321-025-00364-7"},{"key":"26_CR147","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41556-022-01060-1","volume":"25","author":"Y Gao","year":"2023","unstructured":"Gao Y et al. (2023) ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation. Nat Cell Biol 25:298\u2013308","journal-title":"Nat Cell Biol"},{"key":"26_CR148","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13402-021-00640-x","volume":"45","author":"R Khoogar","year":"2022","unstructured":"Khoogar R et al. (2022) Single-cell RNA profiling identifies diverse cellular responses to EWSR1\/FLI1 downregulation in Ewing sarcoma cells. Cell Oncol 45:19\u201340","journal-title":"Cell Oncol"},{"key":"26_CR149","doi-asserted-by":"crossref","first-page":"e1674113","DOI":"10.1080\/2162402X.2019.1674113","volume":"8","author":"D Stahl","year":"2019","unstructured":"Stahl D, Gentles AJ, Thiele R, G\u00fctgemann I (2019) Prognostic profiling of the immune cell microenvironment in Ewing\u00b4s sarcoma family of tumors. Oncoimmunology 8:e1674113","journal-title":"Oncoimmunology"},{"key":"26_CR150","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/2767-9764.CRC-24-0346","volume":"5","author":"JD Daley","year":"2025","unstructured":"Daley JD et al. (2025) TGF\u03b2 inhibition during radiotherapy enhances immune cell infiltration and decreases metastases in Ewing sarcoma. Cancer Res Commun 5:1441\u20131457","journal-title":"Cancer Res Commun"},{"key":"26_CR151","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Serra S et al (2025) Integrative multi-omics reveals PARP14 as a key IFN\u03b3-regulated mediator of metastatic progression in Ewing sarcoma. https:\/\/doi.org\/10.64898\/2025.12.23.696151","DOI":"10.64898\/2025.12.23.696151"},{"key":"26_CR152","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/1878-0261.13788","volume":"19","author":"M Chic\u00f3n-Bosch","year":"2025","unstructured":"Chic\u00f3n-Bosch M et al. (2025) Multi-omics profiling reveals key factors involved in Ewing sarcoma metastasis. Mol Oncol 19:1002\u20131028","journal-title":"Mol Oncol"},{"key":"26_CR153","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1158\/1078-0432.CCR-22-0384","volume":"28","author":"AA Apfelbaum","year":"2022","unstructured":"Apfelbaum AA et al. (2022) EWS::FLI1 and HOXD13 control tumor cell plasticity in Ewing sarcoma. Clin Cancer Res 28:4466\u20134478","journal-title":"Clin Cancer Res"},{"key":"26_CR154","doi-asserted-by":"crossref","first-page":"A015","DOI":"10.1158\/1538-7445.PEDIATRIC25-A015","volume":"85","author":"D Pesic","year":"2025","unstructured":"Pesic D et al. (2025) Abstract A015: targetable gene dependencies in Ewing sarcoma subtypes. Cancer Res 85:A015","journal-title":"Cancer Res"},{"key":"26_CR155","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO.2014.60.6376","volume":"33","author":"C Rodriguez-Galindo","year":"2015","unstructured":"Rodriguez-Galindo C et al. (2015) Toward the cure of all children with cancer through collaborative efforts: pediatric oncology as a global challenge. J Clin Oncol 33:3065\u20133073","journal-title":"J Clin Oncol"}],"container-title":["Methods in Molecular Biology","Ewing Sarcoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5587-0_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:54:25Z","timestamp":1792140865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/chapter\/10.1007\/978-1-0716-5587-0_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"ISBN":["9781071655863","9781071655870"],"references-count":155,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5587-0_26","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"16 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}